![Marcus Irsfeld](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Marcus Irsfeld
Directeur Financier/CFO chez
VIVORYON THERAPEUTICS N.V.
Fortune : - $ au 30/09/2026
Profil
Mr. Marcus Irsfeld is a Chief Financial Officer & Executive Director at Vivoryon Therapeutics NV.
He is on the Board of Directors at Vivoryon Therapeutics NV and Artract Medical, Inc. Mr. Irsfeld was previously employed as a Chief Financial Officer by ProCorde GmbH and a Controller by Trigen Holdings AG.
He received his undergraduate degree from the University of Münster.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 29/09/2026 | 0 ( -.--% ) | - $ | 30/09/2026 |
Postes actifs de Marcus Irsfeld
| Sociétés | Poste | Début |
|---|---|---|
| VIVORYON THERAPEUTICS N.V. | Directeur Financier/CFO | 01/12/2025 |
Artract Medical, Inc.
 Artract Medical, Inc. Medical SpecialtiesHealth Technology Manufactures hemodynamic assist device | Fondateur | - |
Anciens postes connus de Marcus Irsfeld
| Sociétés | Poste | Fin |
|---|---|---|
Trigen Holdings AG
 Trigen Holdings AG Miscellaneous Commercial ServicesCommercial Services Develops drugs focusing on thrombosis and vascular dysfunction | Comptroller/Controller/Auditor | 15/12/2009 |
ProCorde GmbH
 ProCorde GmbH Miscellaneous Commercial ServicesCommercial Services Develops biomedical drugs for cardiovascular diseases | Directeur Financier/CFO | 11/04/2005 |
Formation de Marcus Irsfeld
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
11
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
ProCorde GmbH
ProCorde GmbH Miscellaneous Commercial ServicesCommercial Services Develops biomedical drugs for cardiovascular diseases | Commercial Services |
Trigen Holdings AG
Trigen Holdings AG Miscellaneous Commercial ServicesCommercial Services Develops drugs focusing on thrombosis and vascular dysfunction | Commercial Services |
University of Münster
 University of Münster Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vivoryon Therapeutics NV
 Vivoryon Therapeutics NV Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that is engaged in the research and development of new therapeutic products for the treatment of Alzheimer disease | Commercial Services |
Artract Medical, Inc.
Artract Medical, Inc. Medical SpecialtiesHealth Technology Manufactures hemodynamic assist device | Health Technology |
